featured
Pembrolizumab in Patients With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab in Men With Heavily Treated Metastatic Castrate-Resistant Prostate Cancer
Cancer Med 2019 Jul 03;[EPub Ahead of Print], MD Tucker, J Zhu, D Marin, RT Gupta, S Gupta, WR Berry, S Ramalingam, T Zhang, M Harrison, Y Wu, P Healy, S Lisi, DJ George, AJ ArmstrongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.